Belite Bio Inc Adr (BLTE)

Dec 07, 2024

Belite Bio (NASDAQ:BLTE) Shares Gap UpStill a Buy? - MarketBeat

Dec 07, 2024

Dec 06, 2024

Facebook, UnitedHealth among Friday's market cap stock movers By Investing.com - Investing.com Nigeria

Dec 06, 2024

Dec 06, 2024

Facebook, UnitedHealth among Friday's market cap stock movers - Investing.com India

Dec 06, 2024

Nov 30, 2024

Belite Bio (NASDAQ:BLTE) Trading Down 3.4%What's Next? - MarketBeat

Nov 30, 2024

Nov 23, 2024

Belite Bio (NASDAQ:BLTE) Shares Down 4.5%Here's What Happened - MarketBeat

Nov 23, 2024

Nov 19, 2024

Advancing Stargardt Disease Treatments: 20+ Companies Poised to Accelerate the Therapeutic Pipeline | DelveInsight - GlobeNewswire Inc.

Nov 19, 2024

Nov 18, 2024

Cantor Fitzgerald Predicts Weaker Earnings for Belite Bio - Defense World

Nov 18, 2024

Nov 18, 2024

FY2024 EPS Estimates for Belite Bio Reduced by HC Wainwright - MarketBeat

Nov 18, 2024

Nov 16, 2024

Belite Bio, Inc (NASDAQ:BLTE) Short Interest Down 13.5% in October - MarketBeat

Nov 16, 2024

Nov 15, 2024

Belite Bio (NASDAQ:BLTE) Given New $110.00 Price Target at Maxim Group - MarketBeat

Nov 15, 2024

Nov 15, 2024

Belite Bio (NASDAQ:BLTE) Reaches New 1-Year High After Analyst Upgrade - Defense World

Nov 15, 2024

Nov 14, 2024

Belite Bio stock soars to all-time high of $84.2 amid robust gains - Investing.com UK

Nov 14, 2024

Nov 14, 2024

Earnings call: Belite Bio reports progress in Tinlarebant trials By Investing.com - Investing.com Australia

Nov 14, 2024

Nov 13, 2024

Belite Bio shares target boosted, retains buy rating on trial progress - Investing.com

Nov 13, 2024

Nov 13, 2024

Earnings call: Belite Bio reports progress in Tinlarebant trials - Investing.com

Nov 13, 2024

Nov 12, 2024

Belite Bio Advances in Retinal Disease Trials - TipRanks

Nov 12, 2024

Nov 12, 2024

Belite Bio Advances in Tinlarebant Trials, Appoints New CMO - TipRanks

Nov 12, 2024

Nov 12, 2024

Belite Bio Advances Eye Disease Trials, Posts $109M Cash Position in Q3 Update | BLTE Stock News - StockTitan

Nov 12, 2024

Nov 08, 2024

Riot Platforms Inc (RIOT-Q) QuotePress Release - The Globe and Mail

Nov 08, 2024

Nov 06, 2024

Belite Bio (BLTE) Set to Announce Earnings on Tuesday - MarketBeat

Nov 06, 2024

Nov 05, 2024

Belite Bio (BLTE) Sets Q3 2024 Earnings Call: Key Updates on Retinal Disease Pipeline | BLTE Stock News - StockTitan

Nov 05, 2024

Nov 04, 2024

Belite Bio stock soars to all-time high of $70.4 amid robust growth - Investing.com

Nov 04, 2024

Nov 04, 2024

Belite Bio (NASDAQ:BLTE) Sees Strong Trading VolumeStill a Buy? - MarketBeat

Nov 04, 2024

Nov 04, 2024

Belite Bio Offers New Warrant Opportunities to Investors - TipRanks

Nov 04, 2024

Nov 03, 2024

Belite Bio Announces Exercise of Warrants for US$28.75 Million Gross Proceeds - ForexTV.com

Nov 03, 2024

Oct 29, 2024

Nike Inc (NKE-N) QuotePress Release - The Globe and Mail

Oct 29, 2024

Oct 28, 2024

Belite Bio stock soars to all-time high of $67.6 amid robust gains - Investing.com UK

Oct 28, 2024

Oct 25, 2024

TSX Smallcap Index (TXTW) QuotePress Release - The Globe and Mail

Oct 25, 2024

Oct 24, 2024

Belite Bio (NASDAQ:BLTE) Hits New 52-Week HighHere's What Happened - MarketBeat

Oct 24, 2024

Oct 23, 2024

Belite Bio (NASDAQ:BLTE) Trading Up 4%Should You Buy? - MarketBeat

Oct 23, 2024

Oct 18, 2024

Belite Bio (NASDAQ:BLTE) Hits New 12-Month HighHere's Why - MarketBeat

Oct 18, 2024

Oct 18, 2024

Belite Bio stock soars to all-time high of $56.62 By Investing.com - Investing.com UK

Oct 18, 2024

Oct 16, 2024

Tevogen Bio Thanks Warren Township for Proclamation Honoring CEO Dr. Ryan Saadi, Nobel Peace Prize Nomination, and the Company's Mission to Address Health Inequality - Yahoo Finance

Oct 16, 2024

Oct 14, 2024

Belite Bio Announces Presentations at the American Academy of Ophthalmology 2024 Annual Meeting - The Bakersfield Californian

Oct 14, 2024

Oct 12, 2024

First patient dosed at the Tokyo Medical Center by Belite Bio in Phase 2/3 DRAGON II clinical trial - Ophthalmology Times

Oct 12, 2024

Oct 09, 2024

Belite Bio (NASDAQ:BLTE) Sets New 12-Month HighStill a Buy? - MarketBeat

Oct 09, 2024

Oct 08, 2024

Belite Bio to Participate in the Maxim Group 2024 Healthcare Virtual Summit - The Bakersfield Californian

Oct 08, 2024

Oct 05, 2024

Week in ReviewOctober 5, 2024 - Ophthalmology Times

Oct 05, 2024

Oct 03, 2024

Belite Bio (NASDAQ:BLTE) Hits New 1-Year High at $50.69 - MarketBeat

Oct 03, 2024

Sep 26, 2024

Deutsche Bank ADR Virtual Investor Conference: Presentations Now Available for Online Viewing - GlobeNewswire

Sep 26, 2024

Sep 26, 2024

Armistice Capital LLC Invests $6.76 Million in Belite Bio, Inc (NASDAQ:BLTE) - MarketBeat

Sep 26, 2024

Sep 20, 2024

Servicenow Inc (NOW-N) QuotePress Release - The Globe and Mail

Sep 20, 2024

Sep 19, 2024

International companies to host live webcasts at Deutsche - GlobeNewswire

Sep 19, 2024

Sep 19, 2024

Belite Bio, Inc (NASDAQ:BLTE) Short Interest Down 5.1% in August - MarketBeat

Sep 19, 2024

Sep 14, 2024

Belite Bio (NASDAQ:BLTE) Rating Reiterated by HC Wainwright - Defense World

Sep 14, 2024

Sep 13, 2024

Belite Bio shares hold buy rating, steady target on trial progress - Investing.com

Sep 13, 2024

Sep 12, 2024

Belite Bio's (BLTE) Buy Rating Reiterated at HC Wainwright - MarketBeat

Sep 12, 2024

Sep 10, 2024

Belite Bio Announces First Patient Dosed in Phase 2/3 - GlobeNewswire

Sep 10, 2024

Sep 10, 2024

Belite Bio Announces First Patient Dosed in Phase 2/3 DRAGON II Trial of Tinlarebant for the Treatment of Stargardt Disease - StockTitan

Sep 10, 2024

Sep 03, 2024

Belite Bio Welcomes New Chief Medical Officer - TipRanks

Sep 03, 2024